long-acting insulin, insulin analogs formulated with recombinant DNA technology. These formulations form microprecipitates when injected into the subcutaneous tissue, delaying absorption from the injection site. They do not have a pronounced peak effect and have a duration of action of approximately 24 hours. Compare intermediate-acting insulin, short-acting insulin. See also insulin.
